Literature DB >> 32743550

Intrinsic ATR signaling shapes DNA end resection and suppresses toxic DNA-PKcs signaling.

Diego Dibitetto1, Jennie R Sims1, Carolline F R Ascenção1, Kevin Feng1, Dongsung Kim1, Susannah Oberly1, Raimundo Freire2,3,4, Marcus B Smolka1.   

Abstract

Most cancer cells experience oncogene-induced replication stress and, as a result, exhibit high intrinsic activation of the ATR kinase. Although cancer cells often become more dependent on ATR for survival, the precise mechanism by which ATR signaling ensures cancer cell fitness and viability remains incompletely understood. Here, we find that intrinsic ATR signaling is crucial for the ability of cancer cells to promote DNA end resection, the first step in homology-directed DNA repair. Inhibition of ATR over multiple cell division cycles depletes the pool of pro-resection factors and prevents the engagement of RAD51 as well as RAD52 at nuclear foci, leading to toxic DNA-PKcs signaling and hypersensitivity to PARP inhibitors. The effect is markedly distinct from acute ATR inhibition, which blocks RAD51-mediated repair but not resection and engagement of RAD52. Our findings reveal a key pro-resection function for ATR and define how ATR inhibitors can be used for effective manipulation of DNA end resection capacity and DNA repair outcomes in cancer cells.
© The Author(s) 2020. Published by Oxford University Press on behalf of NAR Cancer.

Entities:  

Year:  2020        PMID: 32743550      PMCID: PMC7380482          DOI: 10.1093/narcan/zcaa006

Source DB:  PubMed          Journal:  NAR Cancer        ISSN: 2632-8674


  78 in total

1.  Cell cycle-dependent complex formation of BRCA1.CtIP.MRN is important for DNA double-strand break repair.

Authors:  Longchuan Chen; Christian J Nievera; Alan Yueh-Luen Lee; Xiaohua Wu
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

Review 2.  Targeting ATR in cancer.

Authors:  Emilio Lecona; Oscar Fernandez-Capetillo
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

3.  Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia.

Authors:  Adele Adamo; Spencer J Collis; Carrie A Adelman; Nicola Silva; Zuzana Horejsi; Jordan D Ward; Enrique Martinez-Perez; Simon J Boulton; Adriana La Volpe
Journal:  Mol Cell       Date:  2010-07-09       Impact factor: 17.970

4.  53BP1 fosters fidelity of homology-directed DNA repair.

Authors:  Fena Ochs; Kumar Somyajit; Matthias Altmeyer; Maj-Britt Rask; Jiri Lukas; Claudia Lukas
Journal:  Nat Struct Mol Biol       Date:  2016-06-27       Impact factor: 15.369

5.  Genetic steps of mammalian homologous repair with distinct mutagenic consequences.

Authors:  Jeremy M Stark; Andrew J Pierce; Jin Oh; Albert Pastink; Maria Jasin
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

6.  RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination.

Authors:  B H Lok; A C Carley; B Tchang; S N Powell
Journal:  Oncogene       Date:  2012-09-10       Impact factor: 9.867

7.  Distinct RAD51 associations with RAD52 and BCCIP in response to DNA damage and replication stress.

Authors:  Justin Wray; Jingmei Liu; Jac A Nickoloff; Zhiyuan Shen
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

8.  Recruitment of ATR to sites of ionising radiation-induced DNA damage requires ATM and components of the MRN protein complex.

Authors:  K E Adams; A L Medhurst; D A Dart; N D Lakin
Journal:  Oncogene       Date:  2006-02-13       Impact factor: 9.867

9.  Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells.

Authors:  Katherine Sullivan-Reed; Elisabeth Bolton-Gillespie; Yashodhara Dasgupta; Samantha Langer; Micheal Siciliano; Margaret Nieborowska-Skorska; Kritika Hanamshet; Elizaveta A Belyaeva; Andrea J Bernhardy; Jaewong Lee; Morgan Moore; Huaqing Zhao; Peter Valent; Ksenia Matlawska-Wasowska; Markus Müschen; Smita Bhatia; Ravi Bhatia; Neil Johnson; Mariusz A Wasik; Alexander V Mazin; Tomasz Skorski
Journal:  Cell Rep       Date:  2018-06-12       Impact factor: 9.423

10.  PRIMPOL-Mediated Adaptive Response Suppresses Replication Fork Reversal in BRCA-Deficient Cells.

Authors:  Annabel Quinet; Stephanie Tirman; Jessica Jackson; Saša Šviković; Delphine Lemaçon; Denisse Carvajal-Maldonado; Daniel González-Acosta; Alexandre T Vessoni; Emily Cybulla; Matthew Wood; Steven Tavis; Luis F Z Batista; Juan Méndez; Julian E Sale; Alessandro Vindigni
Journal:  Mol Cell       Date:  2019-10-29       Impact factor: 17.970

View more
  4 in total

Review 1.  Cell cycle checkpoints and beyond: Exploiting the ATR/CHK1/WEE1 pathway for the treatment of PARP inhibitor-resistant cancer.

Authors:  Nitasha Gupta; Tzu-Ting Huang; Sachi Horibata; Jung-Min Lee
Journal:  Pharmacol Res       Date:  2022-03-05       Impact factor: 10.334

2.  Selective vulnerability of ARID1A deficient colon cancer cells to combined radiation and ATR-inhibitor therapy.

Authors:  Shan Xu; Ali Sak; Ben Niedermaier; Yasin Bahadir Erol; Michael Groneberg; Emil Mladenov; MingWei Kang; George Iliakis; Martin Stuschke
Journal:  Front Oncol       Date:  2022-09-30       Impact factor: 5.738

3.  EXO5-DNA structure and BLM interactions direct DNA resection critical for ATR-dependent replication restart.

Authors:  Shashank Hambarde; Chi-Lin Tsai; Raj K Pandita; Albino Bacolla; Anirban Maitra; Vijay Charaka; Clayton R Hunt; Rakesh Kumar; Oliver Limbo; Remy Le Meur; Walter J Chazin; Susan E Tsutakawa; Paul Russell; Katharina Schlacher; Tej K Pandita; John A Tainer
Journal:  Mol Cell       Date:  2021-06-30       Impact factor: 19.328

Review 4.  To Join or Not to Join: Decision Points Along the Pathway to Double-Strand Break Repair vs. Chromosome End Protection.

Authors:  Stephanie M Ackerson; Carlan Romney; P Logan Schuck; Jason A Stewart
Journal:  Front Cell Dev Biol       Date:  2021-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.